A Meta-Analysis of Studies Evaluating Visual and Anatomical Outcomes in Patients with Treatment Resistant Neovascular Age-Related Macular Degeneration following Switching to Treatment with Aflibercept
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Meta-Analysis of Studies Evaluating Visual and Anatomical Outcomes in Patients with Treatment Resistant Neovascular Age-Related Macular Degeneration following Switching to Treatment with Aflibercept
Authors
Keywords
-
Journal
Journal of Ophthalmology
Volume 2016, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2016-03-07
DOI
10.1155/2016/4095852
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- One-Year Outcomes of Aflibercept in Recurrent or Persistent Neovascular Age-Related Macular Degeneration
- (2015) Cheryl A. Arcinue et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Switch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice
- (2015) Jo�o Pinheiro-Costa et al. OPHTHALMOLOGICA
- Growth of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
- (2015) Juan E. Grunwald et al. OPHTHALMOLOGY
- Early initial clinical experience with intravitreal aflibercept for wet age-related macular degeneration
- (2014) Philip J Ferrone et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- A single-arm, investigator-initiated study of the efficacy, safety and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration, previously treated with ranibizumab or bevacizumab: 6-month interim analysis
- (2014) Rishi P Singh et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Injection frequency and anatomic outcomes 1 year following conversion to aflibercept in patients with neovascular age-related macular degeneration
- (2014) Wyatt B Messenger et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial)
- (2014) Charles C Wykoff et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Visual and anatomical outcomes following intravitreal aflibercept in eyes with recalcitrant neovascular age-related macular degeneration: 12-month results
- (2014) D S Grewal et al. EYE
- Visual and Anatomical Outcomes of Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration
- (2014) Magda Gharbiya et al. Biomed Research International
- Response to Aflibercept After Frequent Re-treatment With Bevacizumab or Ranibizumab in Eyes With Neovascular AMD
- (2014) Mariana R. Thorell et al. Ophthalmic Surgery Lasers & Imaging Retina
- Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab
- (2013) Benjamin Bakall et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab
- (2013) Hyung Cho et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration
- (2013) Andrew A. Chang et al. OPHTHALMOLOGY
- Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
- (2013) Juan E. Grunwald et al. OPHTHALMOLOGY
- VISUAL AND ANATOMICAL OUTCOMES OF INTRAVITREAL AFLIBERCEPT IN EYES WITH PERSISTENT SUBFOVEAL FLUID DESPITE PREVIOUS TREATMENTS WITH RANIBIZUMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2013) Nishant Kumar et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Age-related macular degeneration
- (2012) Laurence S Lim et al. LANCET
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Retinal Pigment Epithelial Cell Loss Assessed by Fundus Autofluorescence Imaging in Neovascular Age-related Macular Degeneration
- (2012) Nishant Kumar et al. OPHTHALMOLOGY
- Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation
- (2011) Julie L Gasperini et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance?
- (2011) Susanne Binder BRITISH JOURNAL OF OPHTHALMOLOGY
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- TACHYPHYLAXIS AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
- (2009) FARZIN FOROOGHIAN et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started